Literature DB >> 10757404

The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system.

C C Pan1, S R Potter, A W Partin, J I Epstein.   

Abstract

The Gleason grading system of prostatic adenocarcinoma does not account for the existence of a tertiary (third most prevalent) pattern, and there are no studies concerning the latter's prognostic influence. The authors analyzed 114 radical prostatectomies with small tertiary components, which mostly occupied less than 5% of whole tumors. These specimens were compared with a prostatectomy database comprised of 2,276 cases without a tertiary component. The pathologic stages of "typical" Gleason score 5 to 6 tumors (Gleason scores 2 + 3 = 5, 3 + 2 = 5, 3 + 3 = 6), which contained tertiary patterns 4 or 5, were significantly higher than those of "typical" Gleason score 5 to 6 tumors without pattern 4 (p = 0.018) but lower than those of "typical" Gleason score 7 tumors (p = 0.021; Gleason scores, 3 + 4 = 7, 4 + 3 = 7). Typical Gleason score 7 tumors with a tertiary pattern 5 showed significantly worse pathologic stages than typical Gleason score 7 tumors (p = 0.008) without pattern 5 and were not different statistically from typical Gleason score 8 (Gleason score, 4 + 4 = 8) tumors. Both typical Gleason score 5 to 6 and 7 tumors with tertiary components revealed significantly higher progression rates than typical Gleason score 5 to 6 tumors (p <0.0001) and Gleason score 7 tumors (p = 0.003) without tertiary components, and progressed like typical Gleason score 7 and 8 tumors respectively. Tertiary high-grade components have an adverse impact on biologic behavior. The authors propose that the Gleason system for radical prostatectomy specimens be modified to take into account small volumes of patterns 4 and 5, which are important prognostically.

Entities:  

Mesh:

Year:  2000        PMID: 10757404     DOI: 10.1097/00000478-200004000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

Review 1.  [The value of the modified Gleason grading system of prostate adenocarcinoma in routine urological diagnostics].

Authors:  B Helpap; L Egevad
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

Review 2.  Current practice of Gleason grading of prostate carcinoma.

Authors:  Antonio Lopez-Beltran; Gregor Mikuz; Rafael J Luque; Roberta Mazzucchelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2005-11-23       Impact factor: 4.064

3.  Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?

Authors:  Hillary M Ross; Oleksandr N Kryvenko; Janet E Cowan; Jeffry P Simko; Thomas M Wheeler; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2012-09       Impact factor: 6.394

Review 4.  What is the pathologist saying? Interpretation of the prostate pathology report.

Authors:  Omar Hameed
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

5.  Temporal changes in the pathologic assessment of prostate cancer.

Authors:  M Scott Lucia; Adrie van Bokhoven
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

6.  Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.

Authors:  Andrew B Rosenkrantz; Michael J Triolo; Jonathan Melamed; Henry Rusinek; Samir S Taneja; Fang-Ming Deng
Journal:  J Magn Reson Imaging       Date:  2014-02-25       Impact factor: 4.813

Review 7.  Grading of Prostate Cancer: Past, Present, and Future.

Authors:  Andres Matoso; Jonathan I Epstein
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

8.  Effect of Gleason scores of lymph node metastases on prognosis of patients with prostate cancer.

Authors:  Kyungtae Ko; In Gab Jeong; Woo Suk Choi; Ju Hyun Lim; Ja Hee Suh; Ja Hyeon Ku; Yangsoon Park; Kyung Cheol Moon; Hyeon Hoe Kim; Choung-Soo Kim; Cheol Kwak
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

9.  Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer.

Authors:  Jeffrey M Bhasin; Byron H Lee; Lars Matkin; Margaret G Taylor; Bo Hu; Yaomin Xu; Cristina Magi-Galluzzi; Eric A Klein; Angela H Ting
Journal:  Cell Rep       Date:  2015-11-25       Impact factor: 9.423

Review 10.  [Trends in prostate biopsy interpretation].

Authors:  J Köllermann; G Sauter
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.